Theriva Biologics, Inc.
TOVXNYSECIK 894158HealthcareFiscal year ends Dec 31
Reports and events: 437 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2020:15 ET | DEF 14A | Proxy statementPeriod 2026-11-18 | 0001104659-26-117417 |
| 2026-08-1112:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001104659-26-093786 |
| 2026-08-1112:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-093782 |
| 2026-08-0612:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-091674 |
| 2026-08-0411:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-090064 |
| 2026-07-0712:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-080962 |
| 2026-06-2921:28 ET | DEF 14A | Proxy statementPeriod 2026-08-03 | 0001104659-26-078859 |
| 2026-06-1112:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-072633 |
| 2026-06-0520:05 ET | 8-K | 8.01 Other events | 0001104659-26-070966 |
| 2026-05-0520:41 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-055689 |
| 2026-05-0520:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055679 |
| 2026-04-3020:45 ET | DEF 14A | Proxy statementPeriod 2026-06-05 | 0001104659-26-052960 |
| 2026-04-1720:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-044906 |
| 2026-04-0920:15 ET | 8-K | 8.01 Other events | 0001104659-26-041507 |
| 2026-03-2312:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-033051 |
| 2026-03-1621:32 ET | DEF 14A | Proxy statementPeriod 2026-04-09 | 0001104659-26-028593 |
| 2026-03-1212:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001104659-26-026767 |
| 2026-03-1212:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-026765 |
| 2026-02-1813:10 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-016792 |
| 2026-02-1213:07 ET | 8-K | 8.01 Other events | 0001104659-26-013907 |
| 2026-01-1214:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-002750 |
| 2026-01-0520:30 ET | DEF 14A | Proxy statementPeriod 2026-02-11 | 0001104659-26-000633 |
| 2025-12-2913:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-124523 |
| 2025-12-1522:21 ET | 8-K | 8.01 Other events | 0001104659-25-121246 |
| 2025-11-1213:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001104659-25-109828 |
| 2025-11-1213:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-109821 |
| 2025-11-1021:33 ET | DEF 14A | Proxy statementPeriod 2025-12-15 | 0001104659-25-109200 |
| 2025-10-2920:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-103774 |
| 2025-10-2419:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-102104 |
| 2025-10-2011:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100608 |
| 2025-10-1721:19 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-100468 |
| 2025-10-1410:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-098882 |
| 2025-10-0812:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-097739 |
| 2025-10-0612:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-096946 |
| 2025-10-0220:01 ET | 8-K | 2.05 Exit or disposal costs | 0001104659-25-096047 |
| 2025-09-0420:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-087465 |
| 2025-08-1112:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001410578-25-001654 |
| 2025-08-1112:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075944 |
| 2025-07-0920:50 ET | DEF 14A | Proxy statementPeriod 2025-08-29 | 0001104659-25-066731 |
| 2025-06-2520:01 ET | 8-K | 8.01 Other events | 0001104659-25-062559 |
| 2025-06-2020:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-061203 |
| 2025-06-0211:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-055181 |
| 2025-05-1412:15 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001410578-25-001242 |
| 2025-05-1412:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048183 |
| 2025-05-0820:30 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-046170 |
| 2025-05-0711:10 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-045309 |
| 2025-03-3112:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-029654 |
| 2025-03-2120:31 ET | S-1/A | Registration statement, amended | 0001104659-25-026682 |
| 2025-03-0621:24 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001410578-25-000285 |
| 2025-03-0621:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-021379 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. Listed shows no prices and gives no investment advice.